New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Regulated (List II)

LABROXIN

5UI/0,5ML/IV/IM Injectable Solution/OXYTOCINE
HIKMA
ManufacturerVerified lab

HIKMA

Public retail price
N/ADZD

Identification

Active ingredient (INN)
OXYTOCINE
Internal code
11 E 089
Country of Origin
Jordan
Pharmaceutical form
IV/IM Injectable Solution
Prescription List
Regulated (List II)
Packaging
B/3
LABROXIN
Clinical View
Regulated (List II)

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Description

Dale first identified oxytocin and its uterine contractile properties in 1906. 13, 7, 20 Like all other neurohypophysial hormones, oxytocin is composed of nine amino acids with a disulfide bridge between the Cys and 6 residues. 13, 7 In the mid-1950s, synthetic oxytocin was successfully synthesized by a biochemist named Vincent du Vigneaud; he was later recognized with a Nobel prize for his work.

Oxytocin continues to be an important tool in modern obstetrics to induce labor when indicated and to manage postpartum hemorrhage. 20, 21 It is estimated that labor induction with oxytocin is used in almost 10% of deliveries globally.

It should be noted that there are risks associated with oxytocin intervention during childbirth.

Oxytocin should be used judiciously only when necessary and by experienced healthcare practitioners.

Although most commonly linked to labor and delivery, oxytocin actually has broad peripheral and central effects.

It plays an important role in pair bonding, social cognition and functioning, and even fear conditioning.

Oxytocin also serves a role in metabolic homeostasis and cardiovascular regulation. 7, 19.

Indications

Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern.

For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to prematurely ruptured membranes. 15, 22 Importantly, oxytocin is not approved or indicated for elective induction of labor.

Oxytocin may be used to reinforce labor in select cases of uterine inertia and as adjunctive therapy in the management of incomplete or inevitable abortion.

In the postpartum period, oxytocin may be used to induced contractions in the 3rd stage of labor and to control postpartum bleeding or hemorrhage.

Pharmacodynamics

Oxytocin is a nonapeptide, pleiotropic hormone that exerts important physiological effects. 6, 8 It is most well known to stimulate parturition and lactation, but also has important physiological influences on metabolic and cardiovascular functions, sexual and maternal behaviour, pair bonding, social cognition, and fear conditioning. 6, 11, 14 It is worth noting that oxytocin receptors are not limited to the reproductive system but can be found in many peripheral tissues and in central nervous system structures including the brain stem and amygdala. 11, 12, 13, 14.

Absorption

Oxytocin is administered parenterally and is fully bioavailable.

It takes approximately 40 minutes for oxytocin to reach steady-state concentrations in the plasma after parenteral administration.

Metabolism

Oxytocin is rapidly removed from the plasma by the liver and kidney.

The enzyme oxytocinase is largely responsible for the metabolism and regulation of oxytocin levels in pregnancy and only a small percentage of the neurohormone is excreted in the urine unchanged. 22, 23 Oxytocinase activity increases throughout pregnancy and peaks in the plasma, placenta and uterus near term.

The placenta is a key source of oxytocinase during gestation and produces increasing amounts of the enzyme in response to increasing levels of oxytocin produced by the mother. 17, 18 Oxytocinase activity is also expressed in mammary glands, heart, kidney, and the small intestine.

Lower levels of activity can be found in the brain, spleen, liver, skeletal muscle, testes, and colon.

The level of oxytocin degradation is negligible in non-pregnant women, men, and cord blood.

Hover over products below to view reaction partners Oxytocin.

Route of Elimination

The enzyme oxytocinase is largely responsible for the metabolism and regulation of oxytocin levels in pregnancy; only a small percentage of the neurohormone is excreted in the urine unchanged. 22, 23.

Half-life

The plasma half-life of oxytocin ranges from 1-6 minutes.

The half-life is decreased in late pregnancy and during lactation.

Clearance

In a study that observed 10 women who were given oxytocin to induce labor, the mean metabolic clearance rate was 7.87 mL/min.

Adverse Effects

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.

Toxicity

Administration of supratherapeutic doses of exogenous oxytocin can lead to myocardial ischemia, tachycardia, and arrhythmias.

High doses can also lead to uterine spasms, hypertonicity, or rupture.

Oxytocin has antidiuretic properties, thus, high daily doses (as a single dose or administered slowly over 24 hours) may lead to extreme water intoxication resulting in maternal seizures, coma, and even death.

The risk of antidiuresis and water intoxication in the mother appears to be greater when fluids are given Oral.

Alternatives